Most biotechnology companies are young companies developing their first products and depend on investor capital for survival. According to BioWorld, biotechnology attracted more than $24.8 billion in financing in 2007 and raised more than $100 billion in the five-year span of 2003-2007.
- For Students
- For Teachers
- Programs
- International BioGENEius Challenge
- Testimonials
- Volunteer Opportunities
- U.S. National BioGENEius Challenge
- Local BioGENEius Challenges
- At-Large BioGENEius Challenge Competition
- Your World Magazine
- About the Institute
- Supporters
- What is Biotechnology?
